Cargando…
TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
Fusarochromanone is an experimental drug with unique and potent anti-cancer activity. Current cancer therapies often incorporate a combination of drugs to increase efficacy and decrease the development of drug resistance. In this study, we used drug combinations and cellular phenotypic screens to ad...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687139/ https://www.ncbi.nlm.nih.gov/pubmed/36428475 http://dx.doi.org/10.3390/biomedicines10112906 |